Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
EWTX: Edgewise Therapeutics, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
EWTX
The Story
EWTX
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-40.2%
Financially safe
Stretched
Debt / equity
0.01×
Interest coverage
0.0×
Current ratio
22.61×
Edgewise Therapeutics, Inc.
EWTX
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Edgewise Therapeutics, Inc.
EWTX
NASDAQ
·
USD
·
Closed
$38.43
−6.54%
$38.43
−$2.69 (6.54%)
52W Range
72th
pctl
Volume
0.80×
avg
Mkt Cap
4.13B
USD
P/E
-23.2
TTM
Div Yield
–
ann
52W Range
72th
pctl
Volume
0.80×
avg
Market Cap
4.13B
USD
P/E Ratio
-23.2
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings